Miguel Emilio García Rodríguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Miguel Emilio García Rodríguez has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Ana Esperanza Jeréz Alvarez
Universidad de Ciencias Médicas de La Habana. Instituto de Oncología y Radiobiología. La Habana, Cuba
2 shared publications - Arian Jesús Cuba Naranjo
Universidad de Ciencias Médicas de Granma. Hospital Militar ¨Carlos Arvelo¨. Unidad de Cuidados Intensivos. Venezuela
2 shared publications - Ariel Sosa Remón
Instituto Nacional de Oncología y Radiobiología. La Habana, Cuba
2 shared publications - Freddy Ednildon Bautista-Vanegas
Kliniken Beelitz GmbH Neurologische Rehabilitationsklinik: Beelitz Heilstätten, Brandenburg, DE. Alemania
2 shared publications - Jhossmar Cristians Auza-Santivañez
Hospital del Gran Chaco “Fray Quebracho” de III nivel. Instituto Académico Científico Quispe-Cornejo. Tarija, Bolivia
2 shared publications - Arián Benavidez Márquez
Hospital Universitario Manuel Ascunce Domenech. Servicio de Anestesiología y Reanimación
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by South American Publishing in South Health and Policy
- Vol. 5, 239
Neurological emergencies in cancer: pathophysiological and prognostic implications with a focus on the elderly
Introduction: Neurological emergencies in cancer patients are associated with high mortality. This mortality rate is particularly prevalent in the older adult population, for whom limited scientific evidence exists. The objective of this review was to describe the pathophysiological mechanisms and prognosis of the main neurological emergencies that occur in older patients with cancer and lead to their admission to the Intensive Care Unit. To this end, a narrative review of the literature available in databases and search engines such as PubMed, Medline, Scopus, Scielo, and Google Scholar was conducted using the search terms: neuro-oncological emergencies, neurological complications, oncological intensive care, prognostic factors for cancer mortality, and their English translations. The review was conducted between November 2024 and March 2025. Forty-nine references from articles that met the inclusion criteria were used. Among the main results, it is worth highlighting that the main neurological complications described are predominantly metabolic encephalopathy, stroke, status epilepticus, and intracranial hypertension. These factors share mechanistic relationships with neurocritical patients in general, although cancer appears to be a significant factor in their onset and mortality prognosis. This is accompanied by other variables of prognostic interest such as advanced age, cancer stage, individual functional status, hyperglycemia, sepsis, septic shock, and artificial ventilation. It is concluded that pathophysiological and prognostic knowledge of critically ill older neuro-oncology patients is still limited and warrants multiple investigations in their own clinical context. This is because the greatest available evidence corresponds to young adult neurocritical patients without cancer.
- 1 January 2026
- Published by South American Publishing in South Health and Policy
- Vol. 5, 239
Open AccessNeurological emergencies in cancer: pathophysiological and prognostic implications with a focus on the elderly
Introduction: Neurological emergencies in cancer patients are associated with high mortality. This mortality rate is particularly prevalent in the older adult population, for whom limited scientific evidence exists. The objective of this review was to describe the pathophysiological mechanisms and prognosis of the main neurological emergencies that occur in older patients with cancer and lead to their admission to the Intensive Care Unit. To this end, a narrative review of the literature available in databases and search engines such as PubMed, Medline, Scopus, Scielo, and Google Scholar was conducted using the search terms: neuro-oncological emergencies, neurological complications, oncological intensive care, prognostic factors for cancer mortality, and their English translations. The review was conducted between November 2024 and March 2025. Forty-nine references from articles that met the inclusion criteria were used. Among the main results, it is worth highlighting that the main neurological complications described are predominantly metabolic encephalopathy, stroke, status epilepticus, and intracranial hypertension. These factors share mechanistic relationships with neurocritical patients in general, although cancer appears to be a significant factor in their onset and mortality prognosis. This is accompanied by other variables of prognostic interest such as advanced age, cancer stage, individual functional status, hyperglycemia, sepsis, septic shock, and artificial ventilation. It is concluded that pathophysiological and prognostic knowledge of critically ill older neuro-oncology patients is still limited and warrants multiple investigations in their own clinical context. This is because the greatest available evidence corresponds to young adult neurocritical patients without cancer.
- Open Access
- 1 August 2025
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 4, 598
Prognostic scale for death in critically ill cancer patients due to neurological complications
Introduction: The scales used to predict death in cancer patients are scarce and have not been adequately validated in populations with neurological complications. Objective: To design a prognostic scale for death in critically ill cancer patients due to neurological complications. Method: An observational, prospective cohort study was conducted from January 2017 to 2024 in the Oncology Intensive Care Unit of the Institute of Oncology and Radiobiology in Havana, Cuba. The study population consisted of 265 patients. Clinical, oncological, laboratory, and life support variables were studied. Binary logistic regression analysis was used to determine the variables with the best prognostic power for the model. The final variable was mortality in the Intensive Care Unit. Results: The final model consisted of the following variables: ECOG III (OR: 3.62; 95% CI: 1.05 - 12.46; p= 0.041), absence of pupillary reflex (OR: 9.35; 95% CI: 2.24 - 38.99; p= 0.002), intracranial hypertension (OR: 17.91; 95% CI: 3.02 - 105.91; p= 0.001), hyperglycemia (OR: 5.85; 95% CI: 2.07 - 16.49; p= 0.001), hypoxemia (OR: 19.09; 95% CI: 2.91 - 61.67; p= 0.000) and artificial mechanical ventilation (OR: 9.59; 95% CI: 2.59 – 35.51; p = 0.001).Conclusions: The prognostic score classified mortality into 3 risk groups: low (0 to 2 points), moderate (3 to 6 points), and high (7 to 13 points). Mortality was higher in patients with higher scores. Internal validation showed excellent calibration and discrimination.
- 1 August 2025
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 4, 598
Open AccessPrognostic scale for death in critically ill cancer patients due to neurological complications
Introduction: The scales used to predict death in cancer patients are scarce and have not been adequately validated in populations with neurological complications. Objective: To design a prognostic scale for death in critically ill cancer patients due to neurological complications. Method: An observational, prospective cohort study was conducted from January 2017 to 2024 in the Oncology Intensive Care Unit of the Institute of Oncology and Radiobiology in Havana, Cuba. The study population consisted of 265 patients. Clinical, oncological, laboratory, and life support variables were studied. Binary logistic regression analysis was used to determine the variables with the best prognostic power for the model. The final variable was mortality in the Intensive Care Unit. Results: The final model consisted of the following variables: ECOG III (OR: 3.62; 95% CI: 1.05 - 12.46; p= 0.041), absence of pupillary reflex (OR: 9.35; 95% CI: 2.24 - 38.99; p= 0.002), intracranial hypertension (OR: 17.91; 95% CI: 3.02 - 105.91; p= 0.001), hyperglycemia (OR: 5.85; 95% CI: 2.07 - 16.49; p= 0.001), hypoxemia (OR: 19.09; 95% CI: 2.91 - 61.67; p= 0.000) and artificial mechanical ventilation (OR: 9.59; 95% CI: 2.59 – 35.51; p = 0.001).Conclusions: The prognostic score classified mortality into 3 risk groups: low (0 to 2 points), moderate (3 to 6 points), and high (7 to 13 points). Mortality was higher in patients with higher scores. Internal validation showed excellent calibration and discrimination.
- Open Access
- 29 October 2024
- Published by Asociacion Colombiana de Dermatologia y Cirugia Dermatologica in Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica
- Vol. 32 (4) , 461-465
Prurigo nodular como manifestación paraneoplásica de un linfoma hodgkin de localización mediastinal
Introducción: el prurigo nodular es una dermatosis crónica muy pruriginosa, que se caracteriza por la aparición de nódulos cutáneos hiperqueratósicos en adultos de mediana edad. En ocasiones puede ser la manifestación inicial de una enfermedad linfoproliferativa. Objetivo: presentar el caso de una paciente con antecedentes de prurigo nodular como manifestación paraneoplásica de un linfoma hodgking mediastinal. Presentación del caso: paciente de 48 años de edad con antecedentes de prurigo nodular. A los tres años del diagnóstico presentó un aumento de volumen de la región anterior del tórax. En los estudios imagenológicos se demostró un tumor del mediastino anterosuperior el cual se concluyó en el estudio histológico como un Linfoma Hodgkin variante esclerosis nodular. Conclusiones: las lesiones en piel de curso crónico pueden ser manifestaciones de neoplasias internas.
- 29 October 2024
- Published by Asociacion Colombiana de Dermatologia y Cirugia Dermatologica in Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica
- Vol. 32 (4) , 461-465
Open AccessPrurigo nodular como manifestación paraneoplásica de un linfoma hodgkin de localización mediastinal
Introducción: el prurigo nodular es una dermatosis crónica muy pruriginosa, que se caracteriza por la aparición de nódulos cutáneos hiperqueratósicos en adultos de mediana edad. En ocasiones puede ser la manifestación inicial de una enfermedad linfoproliferativa. Objetivo: presentar el caso de una paciente con antecedentes de prurigo nodular como manifestación paraneoplásica de un linfoma hodgking mediastinal. Presentación del caso: paciente de 48 años de edad con antecedentes de prurigo nodular. A los tres años del diagnóstico presentó un aumento de volumen de la región anterior del tórax. En los estudios imagenológicos se demostró un tumor del mediastino anterosuperior el cual se concluyó en el estudio histológico como un Linfoma Hodgkin variante esclerosis nodular. Conclusiones: las lesiones en piel de curso crónico pueden ser manifestaciones de neoplasias internas.
- 1 January 2014
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 50 (1) , 46-47
Oligo-Recurrence From a Lung Adenocarcinoma. Usefulness of Resection
- 1 January 2014
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 50 (1) , 46-47
Oligo-Recurrence From a Lung Adenocarcinoma. Usefulness of Resection